Cleveland African American Prostate Cancer Project

Not Applicable

Recruiting

• Conditions: Prostate Cancer

• Registration Number: NCT05469269
• Lead Sponsor: Case Comprehensive Cancer Center

Brief Summary

The purpose of this research is to test intervention strategies that encourage and support Black or African American men who are 40 and older to complete prostate cancer screening, and specifically to complete a prostate-specific antigen (PSA) test.

Detailed Description

This intervention is designed to evaluate the effectiveness of three different approaches to increasing PSA screening in African American men, starting at age 40. The approaches are 1) education and passive navigation, 2) education and active navigation, and 3) education and active navigation with community based outreach. Completion of a PSA blood test is the primary outcome of this study, which will be evaluated four months following the recruitment phase at each shop. At the 4 month follow-up, participants will be asked about PSA completion; participants who completed PSA screening will be asked to provide outcomes from their PSA screening (ie. PSA results and provider recommended next steps), as well as their feelings regarding their screening experience, trust in the screening process, and knowledge about prostate cancer.

Study Timeline

• Study First Submitted: 2022-07-19
• Study First Submitted QC: 2022-07-19
• Study First Posted: 2022-07-21
• Study Start: 2023-06-09
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-21
• Last Update Posted: 2025-05-22
• Primary Completion: 2025-09-30
• Study Completion: 2027-09-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Male
• Target Recruitment: 800

Inclusion Criteria

• ≥40 years old
• Self-identify as Black or African American
• Have a prostate gland (includes biological males, transwomen)
• PSA-naïve or has not received a PSA test in the past 12 months
• Has not had a previous prostate cancer diagnosis
• English speaking
• Ability to consent to study

Exclusion Criteria

• Individuals who have had a prostatectomy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
PSA Screening Test	At 4 months	The number of participants who had a PSA screening test completed.

Secondary Outcome Measures

Name	Time	Method
Primary Care Physician Visit	At 14 months	The number of participants that followed up with a primary care physician for a visit or to establish long-term routine care.
PSA Screening Test	At 14 months	The number of participants who had a PSA screening test completed.

Trial Locations

Locations (1)

Barbershops Local to Cleveland; 🇺🇸 Cleveland, Ohio, United States